Curt R. Hartman

Curt R. Hartman is a declared insider at 2 companies (chief executive); the most frequent names are CONMED Corp and Stryker Corp. In total, 81 filings cover trades dated from 10 February 2010 to 7 November 2024.

In open-market terms, that means 6 purchases worth €866k on one side and 17 sales worth €10.5M on the other. The net balance comes to €9.6M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 25 share grants and 29 option exercises.

A typical purchase (the median) is worth €134k. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 6 purchases with a full 90-day history, the hit rate stands at 83% and the median 90-day move at +20.1%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 8 November 2024, the filings show a share grant worth €1.7M in CONMED Corp. The most recent open-market purchase was published on 13 March 2017, 3,527 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.